Work

Risk of thrombosis associated with oral contraceptive pills use in Japan: a target trial emulation study

Year: 2026
Type: article
Study design: Observational Study
Abstract: The thrombosis risk associated with the latest oral contraceptive pills (OCPs) is unclear. Additionally, few studies have assessed thrombosis risk in Asian OCP users, despite wide variations in thrombosis incidence across ethnic groups. We emulated a target trial using DeSC database, an administrative claims database including monthly claims from medical institutions and pharmacies, health checkups data, and registry information in Japan from April 2014 to January 2023. Women who met both the inclusion and exclusion criteria and were not classified as OCP users served as controls. The participants were followed for one year. 59 thrombotic events (OCP group: 40; control: 19) occurred during the follow-up. The rate ratio (RR) of thrombosis among OCP users compared with control was 2.1 (95% confidence interval, 1.5–2.8). The RR among women using OCPs with 50 μg of ethinyl estradiol (EE) was 2.4 (1.5–3.3), and that among those using OCPs with EE < 50 μg was 1.8 (0.8–2.7). For users of 20 μg of EE, the RR was 1.0 (0–2.0) for norethisterone and 2.3 (0.6–4.1) for drospirenone in the three-year extended follow-up period. Our findings suggest a dose-dependent association between estrogen dose in OCPs and thrombosis onset, with a potentially higher risk for OCPs containing drospirenone in Japan. The thrombosis risk was generally higher among OCP users, both in the one-year and the three-year analyses.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7225879511
FWCI:
Cites:
Cited by:
Related to: 10